Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-02-23FDA Approved: THIORIDAZINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approves a supplemental application for thioridazine hydrochloride from Mylan Pharmaceuticals Inc.
-
FDA approval · 2017-02-23FDA Approved: COMPRO — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for COMPRO (prochlorperazine) from Padagis US LLC.
-
FDA label_change · 2017-02-23FDA Approved: PERPHENAZINE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental labeling application for PERPHENAZINE from Sandoz Inc, resulting in updates to the product's labeling.
-
FDA approval · 2017-02-23FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Hikma Pharmaceuticals USA Inc. to market fluphenazine decanoate, a long-acting injectable antips…
-
FDA approval · 2017-02-23FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for Fluphenazine hydrochloride (generic) by Fresenius Kabi USA, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-02-23FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for chlorpromazine hydrochloride (Upsher-Smith Laboratories), updating an existing product's lab…
-
FDA approval · 2017-02-23FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, LLC.
-
FDA approval · 2017-02-23FDA Approved: HALOPERIDOL — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
The FDA approved a supplemental application for haloperidol from PAI Holdings (PAI Pharma) under ANDA073037, marking an additional approval …
-
FDA approval · 2017-02-23FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, LLC.
-
FDA approval · 2017-02-23FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for fluphenazine hydrochloride from PAI Pharma, finalizing an additional regulatory action for this …
-
FDA approval · 2017-02-23FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for fluphenazine hydrochloride submitted by PAI Holdings, LLC dba PAI Pharma.
-
FDA approval · 2017-02-23FDA Approved: HALOPERIDOL — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for HALOPERIDOL from Lannett Company, Inc., under an Abbreviated New Drug Application (ANDA). Th…
-
FDA approval · 2017-02-23FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for Fluphenazine Decanoate from Fresenius Kabi USA, LLC, related to its continued use as a long-…
-
FDA approval · 2017-02-23FDA Approved: ZYPREXA RELPREVV — Supplemental Application (H2-Pharma LLC)
The FDA approved a supplemental application for ZYPREXA RELPREVV (olanzapine pamoate) submitted by H2-Pharma LLC.
-
FDA approval · 2017-02-23FDA Approved: THIORIDAZINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for thioridazine hydrochloride submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2017-02-23FDA Approved: LOXAPINE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for LOXAPINE from Lannett Company, Inc., granting regulatory approval for an updated/expanded generi…
-
FDA approval · 2017-02-23FDA Approved: VERSACLOZ — Supplemental Application (TruPharma LLC)
The FDA approved a supplemental application for Versacloz (clozapine) filed by TruPharma LLC. The action constitutes FDA approval of the sup…
-
FDA approval · 2017-02-23FDA Approved: REXULTI — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
FDA approved a supplemental application for Rexulti (brexpiprazole) submitted by Otsuka America Pharmaceutical, Inc. The approval updates th…
-
FDA approval · 2017-02-23FDA Approved: VRAYLAR — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for VRAYLAR (cariprazine) submitted by Allergan, Inc.
-
FDA approval · 2017-02-23FDA Approved: ARISTADA — Supplemental Application (Alkermes, Inc.)
The FDA approved a supplemental application for ARISTADA (aripiprazole lauroxil) from Alkermes, Inc., to update the product labeling.
-
FDA approval · 2017-02-23FDA Approved: PERPHENAZINE — Supplemental Application (Wilshire Pharmaceuticals, Inc.)
FDA approved Wilshire Pharmaceuticals’ supplemental application for PERPHENAZINE. The approval updates the generic's regulatory status under…
-
FDA approval · 2017-02-23FDA Approved: THIORIDAZINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for thioridazine hydrochloride (Chartwell RX, LLC), authorizing continued marketing of this antipsyc…
-
FDA approval · 2017-02-23FDA Approved: THIORIDAZINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for thioridazine hydrochloride for Chartwell RX, LLC.
-
FDA approval · 2017-02-23FDA Approved: RISPERDAL CONSTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for Risperdal Consta (risperidone) from Janssen Pharmaceuticals, Inc., granting changes to the produ…
-
FDA approval · 2017-02-23FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
The FDA approved a supplemental application for Clozaril (clozapine) submitted by HLS Therapeutics (USA), Inc., resulting in changes to its …